Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome.

作者: C.J. Glueck , D. Aregawi , M. Winiarska , M. Agioria , G. Luo

DOI: 10.1515/JPEM.2006.19.6.831

关键词:

摘要: Background: In 35 adolescent females (17 ± 2 years) with polycystic ovary syndrome (PCOS), median body mass index (BMI) 30.8 kg/m , we assessed effeicacy of metformin-diet for 1 year reduction weight, insulin, HOMA insulin resistance (IR), cholesterol, triglycerides, and resumption regular menses. Methods: Calories (26% protein, 44% carbohydrate) were targeted to 1,500-1,800/day if BMI was <25 or 1,200-1,500/day ≥25, along 2,550 mg metformin. Results: Median weight fell from 82.7 79.1 kg (p = 0.009), insulins 16.7 13.3 μU/ml <0.0001), IR 3.41 2.74 0.0004), total cholesterol 164 151 mg/dl 0.002), triglyceride 103 85 0.006). The percentage cycles normal menses rose a pre-treatment mean 22% 74%, p < 0.0001. Conclusions: adolescents PCOS, reduces IR, facilitates

参考文章(86)
Michael F. Costello, Polycystic ovary syndrome--a management update. Australian Family Physician. ,vol. 34, pp. 127- 133 ,(2005)
Carla Pelusi, Renato Pasquali, Polycystic ovary syndrome in adolescents: pathophysiology and treatment implications. Treatments in Endocrinology. ,vol. 2, pp. 215- 230 ,(2003) , 10.2165/00024677-200302040-00001
Richard S Legro, Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome. Journal of Pediatric Endocrinology and Metabolism. ,vol. 15, pp. 1367- 1378 ,(2002)
R. Homburg, Polycystic Ovary Syndrome in Adolescence Endocrine development. ,vol. 8, pp. 137- 149 ,(2005) , 10.1159/000084099
C.J Glueck, Ping Wang, Robert Fontaine, Trent Tracy, Luann Sieve-Smith, Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS). Journal of Adolescent Health. ,vol. 29, pp. 160- 169 ,(2001) , 10.1016/S1054-139X(01)00202-6
Mary A Birdsall, Cynthia M Farquhar, Harvey D White, Association between Polycystic Ovaries and Extent of Coronary Artery Disease in Women Having Cardiac Catheterization Annals of Internal Medicine. ,vol. 126, pp. 32- 35 ,(1997) , 10.7326/0003-4819-126-1-199701010-00005
Maria Trent, S. Bryn Austin, Michael Rich, Catherine M. Gordon, Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life. Ambulatory Pediatrics. ,vol. 5, pp. 107- 111 ,(2005) , 10.1367/A04-130R.1
E. O. Talbott, J. V. Zborowski, J. R. Rager, M. Y. Boudreaux, D. A. Edmundowicz, D. S. Guzick, Evidence for an Association between Metabolic Cardiovascular Syndrome and Coronary and Aortic Calcification among Women with Polycystic Ovary Syndrome The Journal of Clinical Endocrinology and Metabolism. ,vol. 89, pp. 5454- 5461 ,(2004) , 10.1210/JC.2003-032237
Naila Goldenberg, Charles J. Glueck, Matt Loftspring, Adam Sherman, Ping Wang, Metformin-diet benefits in women with polycystic ovary syndrome in the bottom and top quintiles for insulin resistance☆ Metabolism-clinical and Experimental. ,vol. 54, pp. 113- 121 ,(2005) , 10.1016/J.METABOL.2004.08.007
A Oren, L E Vos, C S P M Uiterwaal, W H M Gorissen, D E Grobbee, M L Bots, Change in body mass index from adolescence to young adulthood and increased carotid intima-media thickness at 28 years of age: the Atherosclerosis Risk in Young Adults study. International Journal of Obesity. ,vol. 27, pp. 1383- 1390 ,(2003) , 10.1038/SJ.IJO.0802404